Advertisement

Current Gastroenterology Reports

, Volume 13, Issue 2, pp 150–156 | Cite as

Pancreas Divisum

  • Matthew J. DiMagnoEmail author
  • Erik-Jan Wamsteker
Article

Abstract

We review important new clinical observations in pancreas divisum (PD) made since 2007. PD is common and has the same prevalence in the general population and idiopathic pancreatitis (IP). Up to 53% of patients with PD and IP have underlying idiopathic chronic pancreatitis (CP), and in rigorous prospective clinical follow-up and/or natural history studies, many with idiopathic recurrent acute pancreatitis (IRAP) have idiopathic CP. According to retrospective studies, PD does not modify the natural course of nonalcoholic or alcoholic CP. CFTR and/or SPINK1 gene mutations associate with IP (idiopathic CP and IRAP) independently of the presence of PD. More than one third of patients with pancreatitis or presumed pancreaticobiliary pain respond to placebo. Authors of uncontrolled studies report a significant symptomatic response to surgery and endotherapy in patients with IP and PD, but the response remains unproven and is largely limited to those with IRAP and not idiopathic CP or chronic pain.

Keywords

Pancreas divisum Acute pancreatitis Chronic pancreatitis Sphincterotomy 

Notes

Disclosure

Conflicts of interest: M. DiMagno is supported by National Institutes of Health grants K08 DK073298 and R21 AA017271; E-J. Wamsteker—none.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    • Fogel EL, Toth TG, Lehman GA, et al.: Does endoscopic therapy favorably affect the outcome of patients who have recurrent acute pancreatitis and pancreas divisum? Pancreas (2007) 34(1):21–45. To address an important and long-standing controversy in clinical pancreatology, this two-part discussion focuses on data and arguments for and against endoscopic therapy for patients with recurrent acute pancreatitis and PD. Coauthors Fogel, Toth, and Lehman report “The Case for Endoscopic Therapy” and coauthors DiMagno and DiMagno report “The Cases Against Endoscopic Therapy.” The section by DiMagno and DiMagno also includes multiple new analyses of the world’s literature to report prevalence data of PD in idiopathic pancreatitis based on whether data were derived from autopsy, endoscopic, or MRCP literature. CrossRefPubMedGoogle Scholar
  2. 2.
    Layer P, Yamamoto H, Kalthoff L, et al.: The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology (1994) 107(5):1481–1487.PubMedGoogle Scholar
  3. 3.
    DiMagno MJ, Wamsteker EJ, Lee A: Chronic Pancreatitis. BMA House, London (2009). https://online.epocrates.com/u/291167/Chronic+pancreatitis
  4. 4.
    Cotton PB: Congenital anomaly of pancreas divisum as cause of obstructive pain and pancreatitis. Gut (1980) 21(2):105–114.CrossRefPubMedGoogle Scholar
  5. 5.
    Sahel J, Cros RC, Bourry J, Sarles H: Clinico-pathological conditions associated with pancreas divisum. Digestion (1982) 23(1):1–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Richter JM, Schapiro RH, Mulley AG, Warshaw AL: Association of pancreas divisum and pancreatitis, and its treatment by sphincteroplasty of the accessory ampulla. Gastroenterology (1981) 81(6):1104–1110.PubMedGoogle Scholar
  7. 7.
    Burtin P, Person B, Charneau J, Boyer J: Pancreas divisum and pancreatitis: a coincidental association? Endoscopy (1991) 23(2):55–58.CrossRefPubMedGoogle Scholar
  8. 8.
    Delhaye M, Engelholm L, Cremer M: Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology (1985) 89(5):951–958.PubMedGoogle Scholar
  9. 9.
    Sugawa C, Walt AJ, Nunez DC, Masuyama H: Pancreas divisum: is it a normal anatomic variant? Am J Surg (1987) 153(1):62–67.CrossRefPubMedGoogle Scholar
  10. 10.
    Bernard JP, Sahel J, Giovannini M, Sarles H: Pancreas divisum is a probable cause of acute pancreatitis: a report of 137 cases. Pancreas (1990) 5(3):248–254.CrossRefPubMedGoogle Scholar
  11. 11.
    • Liao Z, Gao R, Wang W, et al.: A systematic review on endoscopic detection rate, endotherapy, and surgery for pancreas divisum. Endoscopy (2009) 41(5):439–444. A systematic review of ERCP detection rates for PD reported a 2.9% prevalence of PD out of 31,413 ERCPs from 17 studies. PD prevalence varied by different geographic regions, but these apparent regional differences are likely attributable to the degree that endoscopists search for PD (by examining both ductal systems), to referral bias, or to other factors. CrossRefPubMedGoogle Scholar
  12. 12.
    Ammann RW: Alcoholic chronic pancreatitis: its relation to alcoholic acute pancreatitis. Gastroenterol Clin Biol (1996) 20(3):312–314.PubMedGoogle Scholar
  13. 13.
    Comfort MW, Gambill EE, Baggenstoss AH: Chronic relapsing pancreatitis: a study of 29 cases without associated disease of the biliary or gastro-intestinal tract (continued). Gastroenterology (1946) 6(376–408.PubMedGoogle Scholar
  14. 14.
    Barthet M, Valantin V, Spinosa S, et al.: Clinical course and morphological features of chronic calcifying pancreatitis associated with pancreas divisum. Eur J Gastroenterol Hepatol (1995) 7(10):993–998.CrossRefPubMedGoogle Scholar
  15. 15.
    • Spicak J, Poulova P, Plucnarova J, et al.: Pancreas divisum does not modify the natural course of chronic pancreatitis. J Gastroenterol (2007) 42(2):135–139. In a population with predominantly alcoholic chronic pancreatitis, groups with and without PD showed no significant differences among gender, age at onset of disease, clinical presentation, course of disease, and frequency of complications. CrossRefPubMedGoogle Scholar
  16. 16.
    Draganov P, Forsmark CE: “Idiopathic” pancreatitis. Gastroenterology (2005) 128(3):756–763.CrossRefPubMedGoogle Scholar
  17. 17.
    Vila JJ, Vicuna M, Irisarri R, et al.: Diagnostic yield and reliability of endoscopic ultrasonography in patients with idiopathic acute pancreatitis. Scand J Gastroenterol (2010) 45(3):375–381.CrossRefPubMedGoogle Scholar
  18. 18.
    Yadav D, Lowenfels AB: Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas (2006) 33(4):323–330.CrossRefPubMedGoogle Scholar
  19. 19.
    Garg PK, Tandon RK, Madan K: Is biliary microlithiasis a significant cause of idiopathic recurrent acute pancreatitis? A long-term follow-up study. Clin Gastroenterol Hepatol (2007) 5(1):75–79.CrossRefPubMedGoogle Scholar
  20. 20.
    Jacob L, Geenen JE, Catalano MF, Geenen DJ: Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis: a prospective nonblinded randomized study using endoscopic stents. Endoscopy (2001) 33(7):559–562.CrossRefPubMedGoogle Scholar
  21. 21.
    Yusoff IF, Raymond G, Sahai AV: A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis. Gastrointest Endosc (2004) 60(5):673–678.CrossRefPubMedGoogle Scholar
  22. 22.
    Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet (1996) 14(2):141–145.CrossRefPubMedGoogle Scholar
  23. 23.
    Simon P, Weiss FU, Zimmer KP, et al.: Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA (2002) 288(17):2122.CrossRefPubMedGoogle Scholar
  24. 24.
    Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med (1998) 339(10):653–658.CrossRefPubMedGoogle Scholar
  25. 25.
    Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med (1998) 339(10):645–652.CrossRefPubMedGoogle Scholar
  26. 26.
    Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet (2000) 25(2):213–216.CrossRefPubMedGoogle Scholar
  27. 27.
    Rossi L, Pfutzer RH, Parvin S, et al.: SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology (2001) 1(3):242–245.CrossRefPubMedGoogle Scholar
  28. 28.
    Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology (2001) 121(6):1310–1319.CrossRefPubMedGoogle Scholar
  29. 29.
    DiMagno EP: Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing. Gastroenterology (2001) 121(6):1508–1512.CrossRefPubMedGoogle Scholar
  30. 30.
    Bishop MD, Freedman SD, Zielenski J, et al.: The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet (2005) 1–10.Google Scholar
  31. 31.
    Choudari CP, Imperiale TF, Sherman S, et al.: Risk of pancreatitis with mutation of the cystic fibrosis gene. Am J Gastroenterol (2004) 99(7):1358–1363.CrossRefPubMedGoogle Scholar
  32. 32.
    Aoun E, Muddana V, Papachristou GI, Whitcomb DC: SPINK1 N34S is strongly associated with recurrent acute pancreatitis but is not a risk factor for the first or sentinel acute pancreatitis event. Am J Gastroenterol (2010) 105(2):446–451.CrossRefPubMedGoogle Scholar
  33. 33.
    Steinberg WM, Chari ST, Forsmark CE, et al.: Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis. Pancreas (2003) 27(2):103–117.CrossRefPubMedGoogle Scholar
  34. 34.
    Pezzilli R, Morselli-Labate AM, Mantovani V, et al.: Mutations of the CFTR gene in pancreatic disease. Pancreas (2003) 27(4):332–336.CrossRefPubMedGoogle Scholar
  35. 35.
    Kopelman H, Durie P, Gaskin K, et al.: Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. New England Journal of Medicine (1985) 312(6):329–334.CrossRefPubMedGoogle Scholar
  36. 36.
    DiMagno MJ, Lee SH, Hao Y, et al.: A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice. Gastroenterology (2005) 129(2):665–681.PubMedGoogle Scholar
  37. 37.
    DiMagno MJ, Lee SH, Owyang C, Zhou SY: Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse. Am J Physiol Gastrointest Liver Physiol (2010) 299(2):G400–412.CrossRefPubMedGoogle Scholar
  38. 38.
    Rosendahl J, Witt H, Szmola R, et al: Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2008) 40(1):78–82.CrossRefPubMedGoogle Scholar
  39. 39.
    Felderbauer P, Hoffmann P, Einwachter H, et al.: A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol (2003) 3(1):34.CrossRefPubMedGoogle Scholar
  40. 40.
    Muddana V, Lamb J, Greer JB, et al.: Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol. World J Gastroenterol (2008) 14(28):4486–4491.CrossRefPubMedGoogle Scholar
  41. 41.
    Groman JD, Meyer ME, Wilmott RW, et al.: Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med (2002) 347(6):401–407.CrossRefPubMedGoogle Scholar
  42. 42.
    Knowles MR, Durie PR: What is cystic fibrosis? N Engl J Med (2002) 347(6):439–442.CrossRefPubMedGoogle Scholar
  43. 43.
    Ko SB, Mizuno N, Yatabe Y, et al.: Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology (2010) 138(5):1988–1996.CrossRefPubMedGoogle Scholar
  44. 44.
    Gelrud A, Sheth S, Banerjee S, et al: Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol (2004) 99(8):1557–1562.CrossRefPubMedGoogle Scholar
  45. 45.
    Garg PK, Khajuria R, Kabra M, et al.: Association of SPINK1 gene mutation and CFTR gene polymorphisms in patients with pancreas divisum presenting with idiopathic pancreatitis. J Clin Gastroenterol, 2009. 43(9): p. 848–52.CrossRefPubMedGoogle Scholar
  46. 46.
    Wilcox CM: Endoscopic therapy for pain in chronic pancreatitis: Is it time for the naysayers to throw in the towel? Gastrointest Endosc (2005) 61(4):582–586.CrossRefPubMedGoogle Scholar
  47. 47.
    Toskes PP, Forsmark CE, DeMeo MT, et al: An open-label trial of octreotide for the pain of chronic pancreatitis. Gastroenterology (1994) 106(A326.Google Scholar
  48. 48.
    Shiratori K, Takeuchi T, Satake K, Matsuno S: Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. Pancreas (2002) 25(1):e1–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Bhardwaj P, Garg PK, Maulik SK, et al.: A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology (2009) 136(1):149–159 e142.Google Scholar
  50. 50.
    Cahen DL, Gouma DJ, Nio Y, et al.: Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med (2007) 356(7):676–684.CrossRefPubMedGoogle Scholar
  51. 51.
    Cooperman AM, Siegel J, Hammerman H: Pancreas divisum—advocates and agnostics. J Clin Gastroenterol (1989) 11(5):489–491.CrossRefPubMedGoogle Scholar
  52. 52.
    • Chacko LN, Chen YK, Shah RJ: Clinical outcomes and nonendoscopic interventions after minor papilla endotherapy in patients with symptomatic pancreas divisum. Gastrointest Endosc (2008) 68(4):667–673. The authors report that minor papilla endotherapy of patients with PD results in a clinical response or improvement in 76% with IRAP, but only 42% of those with chronic pancreatitis and 33% with chronic abdominal pain. The authors conclude that endoscopic therapy is a reasonable first step in the absence of chronic pain, but also acknowledge that short-term follow-up may be inadequate to assess response in some patients with IRAP who have long pain-free intervals and/or develop chronic pain. CrossRefPubMedGoogle Scholar
  53. 53.
    Ahmed F, Sherman S: Minor papilla endotherapy in patients with symptomatic pancreas divisum. Gastrointest Endosc (2008) 68(4):674–675.CrossRefPubMedGoogle Scholar
  54. 54.
    Delhaye M, Matos C, Arvanitakis M, Deviere J: Pancreatic ductal system obstruction and acute recurrent pancreatitis. World J Gastroenterol (2008) 14(7):1027–1033.CrossRefPubMedGoogle Scholar
  55. 55.
    Lowes JR, Lees WR, Cotton PB: Pancreatic duct dilatation after secretin stimulation in patients with pancreas divisum. Pancreas (1989) 4(3):371–374.CrossRefPubMedGoogle Scholar
  56. 56.
    Ng WK, Tarabain O: Pancreas divisum: a cause of idiopathic acute pancreatitis. CMAJ (2009) 180(9):949–951.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Internal Medicine, Division of Gastroenterology and HepatologyUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations